Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

Packer, M; McMurray, JJV; Krum, H; Kiowski, W; Massie, BM; Caspi, A; Pratt, CM; Petrie, MC; DeMets, D; Kobrin, I; Roux, S; Swedberg, K; Connally, E; Anderson, S; Barnet, J; Cody, R; Dargie, H; Francis, G; Greenberg, B; Reichen, J; Karrasch, J; Horowitz, J; Amerena, J; Sindone, A; MacDonald, P; Jeffrey, I; Button, I; DeAngelis, E; Pacher, R; Davies, R; McAlister, F; Tanser, P; Sussex, B; Baumann, G; Fleck, E; Olbrich, HG; Werdan, K; Klein, H; Staffeld, F; Zeiher, AM; Roediger, C; Marmor, A; Reisin, L; Vered, Z; Klainman, E; Roguin, N; Tzivoni, D; David, D; Lewis, B; Abinader, E; Omary, M; Rosenman, Y; Kaluski, E; Breedveld, RW; van der Burgh, PH; Dunselman, PHJM; Schaafsma, HJ; Hertzberger, DP; Holwerda, NJ; Kragten, JA; van Wijngaarden, J; Posma, JL; Said, SAM; Slegers, LC; Tjon Joe Gin, RM; Wempe, FN; Wesdorp, JCL; Willems, AR; Withagen, AJAM; Cornel, JM; van Kempen, LHJ; Bertel, O; Moccetti, T; Greenbaum, RA; Bennett, P; Swan, J; Davies, G; Findlay, I; Gould, B; Ball, S; Hubner, P; Lahiri, A; McLay, J; Northcote, R; Saltissi, S; Squire, I; Stephens, J; Stewart, M; Bridgen, G; Walsh, J; Webb, DJ; Ansari, Z; Baron, S; Bellinger, R; Bennet, W; Benvenuti, D; Dawley, D; Egbujiobi, LC; Eisenstein, I; Little, T

amerena-longtermeffect-2017.pdf (698.77 kB)

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

Version 2 2024-06-13, 14:47

Version 1 2021-10-20, 16:29

journal contribution

posted on 2024-06-13, 14:47 authored by M Packer, JJV McMurray, H Krum, W Kiowski, BM Massie, A Caspi, CM Pratt, MC Petrie, D DeMets, I Kobrin, S Roux, K Swedberg, E Connally, S Anderson, J Barnet, R Cody, H Dargie, G Francis, B Greenberg, J Reichen, J Karrasch, J Horowitz, J Amerena, A Sindone, P MacDonald, I Jeffrey, I Button, E DeAngelis, R Pacher, R Davies, F McAlister, P Tanser, B Sussex, G Baumann, E Fleck, HG Olbrich, K Werdan, H Klein, F Staffeld, AM Zeiher, C Roediger, A Marmor, L Reisin, Z Vered, E Klainman, N Roguin, D Tzivoni, D David, B Lewis, E Abinader, M Omary, Y Rosenman, E Kaluski, RW Breedveld, PH van der Burgh, PHJM Dunselman, HJ Schaafsma, DP Hertzberger, NJ Holwerda, JA Kragten, J van Wijngaarden, JL Posma, SAM Said, LC Slegers, RM Tjon Joe Gin, FN Wempe, JCL Wesdorp, AR Willems, AJAM Withagen, JM Cornel, LHJ van Kempen, O Bertel, T Moccetti, RA Greenbaum, P Bennett, J Swan, G Davies, I Findlay, B Gould, S Ball, P Hubner, A Lahiri, J McLay, R Northcote, S Saltissi, I Squire, J Stephens, M Stewart, G Bridgen, J Walsh, DJ Webb, Z Ansari, S Baron, R Bellinger, W Bennet, D Benvenuti, D Dawley, LC Egbujiobi, I Eisenstein, T Little

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

History

Journal

JACC: Heart Failure

Volume

5

Pagination

317-326

Location

Amsterdam, The Netherlands

Publisher DOI

https://doi.org/10.1016/j.jchf.2017.02.021

Open access

Yes

Link to full text

https://doi.org/10.1016/j.jchf.2017.02.021

ISSN

2213-1779

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

5

Publisher

Elsevier

Usage metrics

Keywords

3201 Cardiovascular medicine and haematology

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

History

Journal

Volume

Pagination

Location

Publisher DOI

Open access

Link to full text

ISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports